packageTriaziquone

triaziquone

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Triaziquone is an alkylating antineoplastic agent that was developed for cancer treatment. It is no longer in routine clinical use and is regarded as an experimental compound.

Summary written by glm-5.3-flash from Wikidata Q1323947 and the WHO ATC classification; not checked by a person.

name:triaziquone
ATC codes:L01AC02
DrugBank:DB13304
PubChem CID:6235
ChEBI:27090
Wikidata:Q1323947
formula:C12H13N3O2
molar mass:231.255 g/mol (PubChem CID 6235)
logP:-0.1 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown